Adalimumab (Humira) is given to a client for the treatment of rheumatoid arthritis. Which of the following side effect is associated with the medication?

Correct Answer: D

Rationale: Adalimumab, a tumor necrosis factor (TNF) inhibitor, is associated with weight gain as a potential side effect. This may occur due to fluid retention or changes in metabolism. Numbness, constipation, and urinary retention are not commonly linked to adalimumab. Weight gain is a significant consideration for patients, as it can impact their overall health and adherence to treatment. Monitoring for this side effect is important, and dietary or lifestyle interventions may be necessary to manage it effectively.

Correct Answer: A

Rationale: When a client receives total parenteral nutrition (TPN), monitoring blood glucose levels is critical due to the high glucose content in TPN solutions, which can lead to hyperglycemia. This condition arises because TPN delivers concentrated nutrients directly into the bloodstream, bypassing the digestive system, and the body may struggle to regulate sugar levels effectively without proper insulin response. Potassium levels, while important in overall electrolyte balance, are less immediately impacted by TPN compared to glucose, as potassium imbalances typically develop over time rather than acutely from TPN initiation. Mental status assessments are valuable for neurological conditions but lack direct relevance to TPN's metabolic effects. Similarly, blood pressure monitoring is essential for cardiovascular health but isn't the primary concern with TPN, as it doesn't directly influence hypertension or hypotension in the same way glucose dysregulation does. The focus on glucose stems from its rapid impact on the client's metabolic state, making it the priority assessment to prevent complications like hyperglycemia, which can escalate to severe outcomes if unaddressed. Regular monitoring ensures timely intervention, aligning with TPN's nutritional goals.

Correct Answer: C

Rationale: High drug costs stem from research, development, and production expenses-years of trials and manufacturing-requiring companies to recover investments, a factual explanation. Insurance coverage sidesteps the question. Advertising adds cost but isn't primary. Accountability is opinion, not answer. Development costs provide a clear, neutral reason, educating the client on pharmaceutical economics.

Correct Answer: B

Rationale: Herbals (e.g., St. John's wort) transfer to breast milk, risking infant effects (e.g., sedation), so avoiding them is safest, per pharmacokinetics. Labels lack consistent breastfeeding data. ‘Natural' doesn't mean safe-some are toxic. Timing doesn't eliminate transfer. Transfer risk advises caution, protecting the baby.

Correct Answer: D

Rationale: Methylphenidate for ADHD risks appetite suppression-maintaining weight is priority, per side effect monitoring, as growth lags can occur. Avoiding fights, chores, and play improve but aren't immediate risks. Weight reflects health impact, key in kids.